AXIAL SPONDYLOARTHRITIS

This study is testing a live attenuated dengue vaccine (Butantan-DV) in people aged 12–59 with autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) who are stable and on low or no immune-suppressing drugs. Researchers want to see if the vaccine triggers a good immun…

This study compares two ways of giving the drug bimekizumab to people with active psoriatic arthritis or axial spondyloarthritis: as an IV infusion or a shot under the skin. Researchers want to see if the IV version works just as well as the shot. About 392 adults who are suitabl…

This study tests a new medicine called SPY002-072 in adults with moderate-to-severe rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. About 285 participants will receive either the drug or a placebo to see if it reduces joint swelling and pain. The goal is to…

This study looks at how much of the drug bimekizumab ends up in the breast milk of mothers who are already taking it for conditions like psoriasis or arthritis. About 20 breastfeeding women will provide milk samples over several weeks. The goal is to understand possible exposure …

This study follows 2,250 adults in China with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine) to see how the disease progresses over time. Researchers will measure changes in physical function, spinal damage on X-rays, and episodes of eye inflammati…